Striatum- and testis-specific phosphodiesterase PDE10A: Isolation and characterization of a rat PDE10A

European Journal of Biochemistry

Volumn 266, Issue 3, 1999, Pages 1118-1127

  Fujishige, Kotomi ^a   Kotera, Jun ^a   Omori, Kenji ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

PDE10; Phosphodiesterase; Striatum; Testis

Indexed keywords

COMPLEMENTARY DNA; CYCLIC AMP; CYCLIC GMP; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DNA LIBRARY; ENZYME ISOLATION; IN SITU HYBRIDIZATION; MALE; MICHAELIS CONSTANT; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OLFACTORY BULB; PRIORITY JOURNAL; RAT; RNA PROBE; TESTIS; TISSUE SPECIFICITY;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHROMATOGRAPHY, ION EXCHANGE; CLONING, MOLECULAR; CORPUS STRIATUM; COS CELLS; DNA PRIMERS; DNA, COMPLEMENTARY; HUMANS; IN SITU HYBRIDIZATION; KINETICS; MALE; MOLECULAR SEQUENCE DATA; PHOSPHORIC DIESTER HYDROLASES; RATS; RECOMBINANT PROTEINS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TESTIS; TISSUE DISTRIBUTION; TRANSFECTION; VARIATION (GENETICS);

EID: 0033572982     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00963.x     Document Type: Article

References (38)

1. 1. Kukovetz, W.R., Holzmann, S., Wurm, A. & Poch, G. (1979) Evidence for cyclic GMP-mediated relaxant effects of nitrocompounds in coronary smooth muscle. Naunyn Schmiedeberg's Arch. Pharmacol. 310, 129-138.
2. 2. Schramm, M. & Selinger, Z. (1984) Messenger transmission: receptor controlled adenylate cyclase system. Science 225, 1350-1356.
3. 3. Ignarro, L.J. & Kadowits, P.J. (1985) The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu. Rev. Pharmacol. Toxicol. 25, 171-191.
4. 4. Martin, W., Furchgott, R.F., Villani, G.M. & Jothianandan, O. (1986) Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor. J. Pharmacol. Exp. Ther. 237, 539-547.
5. 5. Beavo, J.A. & Houslay, M.D. (1990) Cyclic Nucleotide Phosphodiesterase: Structure, Regulation and Drug Action, Vol. 2. John Wiley & Sons, Chichester, UK.
6. 6. Beavo, J.A. (1995) Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol. Rev. 75, 725-748.
7. 7. Soderling, S.H., Bayuga, S.J. & Beavo, J.A. (1998) Cloning and characterization of cAMP-specific cyclic nucleotide phosphodiesterase. Proc. Natl Acad. Sci. USA 95, 8991-8996.
8. 8. Fisher, D.A., Smith, J.F., Pillar, J.S., St. Denis, S.H. & Cheng, J.B. (1998) Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. Biochem. Biophys. Res. Commun. 246, 570-577.
9. 9. Soderling, S.H., Bayuga, S.J. & Beavo, J.A. (1998) Identification and characterization of a novel family of cyclic nucleotide phosphodiesterases. J. Biol. Chem. 273, 15553-15558.
10. 10. Fisher, D.A., Smith, J.F., Pillar, J.S., St. Denis, S.H. & Cheng, J.B. (1998) Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase. J. Biol. Chem. 273, 15559-15564.
11. 11. Fujishige, K., Kotera, J., Michibata, H., Yuasa, K., Takebayashi, S., Okumura, K. & Omori, K. (1999) Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP. J. Biol. Chem. 274, 18438-18445.
12. 12. Conti, M., Nemoz, G., Sette, C. & Vicini, E. (1995) Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocrine Rev. 16, 370-389.
13. 13. Van, C., Bentley, J.K., Sonnenburg, W.K. & Beavo, J.A. (1994) Differential expression of the 61 kDa and 63 kDa calmodulin-dependent phosphodiesterase in the mouse brain. J. Neurosci. 14, 973-984.
14. 14. Polli, J.W. & Kincaid, R.L. (1994) Expression of a calmodulin-dependent phosphodiesterase isoform (PDE1B1) correlates with brain regions having extensive dopaminergic innervation. J. Neurosci. 14, 1251-1261.
15. 15. Reinhardt, R.R., Chin, E., Zhou, J., Taira, M., Murata, T., Manganiello, V.C. & Bond, C.A. (1995) Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases. J. Clin. Invest. 95, 1528-1538.
16. 16. McPhee, I., Pooley, L., Lobban, M., Bolger, G. & Houslay, M.D. (1995) Identification, characterization, a novel splice variant of the PDE4A cyclic AMP phosphodiesterase family. Biochem. J. 310, 965-974.
17. 17. Yan, C., Zhao, A.Z., Bentley, J.K. & Beavo, J.A. (1996) The calmodulin-dependent phosphodiesterase gene PDE1C encodes several functionally different splice variants in a tissue-specific manner. J. Biol. Chem. 271, 25699-25706.
18. 18. Bolger, G.B., McPhee, I. & Houslay, M.D. (1996). Alternative splicing of cAMP-specific phosphodiesterase mRNA transcripts. Characterization of a novel tissue-specific isoform, RNPDE4A8. J. Biol. Chem. 271, 1065-1071.
19. 19. Huston, E., Pooley, L., Julien, P., Scotland, G., McPhee, I., Sullivan, M., Bolger, G. & Houslay, M.D. (1996) The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram. J. Biol. Chem. 271, 31334-31344.
20. 20. Han, P., Zhu, X. & Michaeli, T. (1997) Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart. J. Biol. Chem. 272, 16152-16157.
21. 21. Degerman, E., Beifrage, P. & Manganiello, V.C. (1997) Structure, localization and regulation of cGMP-inhibited phosphodiesterase (PDE3). J. Biol. Chem. 272, 6823-6826.
22. 22. O'Connell, J.C., McCallum, J.F., McPhee, I., Wakefield, J., Houslay, E.S., Wishart, W., Bolger, G., Frame, M. & Houslay, M.D. (1996) The SH3 domain of src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5). Biochem. J. 318, 255-262.
23. 23. Scotland, G. & Houslay, M.D. (1995) Chimeric constructs show that the unique N-terminal domain of the cyclic AMP phosphodiesterase RD1 (RNPDE4A1A; rPDE-IVa1) can confer membrane association upon the normally cytosolic protein chloramphenicol acelyltransferase. Biochem. J. 308, 673-681.
24. 24. Shakur, Y., Pryde, J.G. & Houslay, M.D. (1993) Engineered deletion of the unique N-terminal domain of the cyclic AMP-specific phosphodiesterase RDI prevents plasma membrane association and the attainment of enhanced thermostability without altering its sensitivity to inhibition by rolipram. Biochem. J. 292, 677-686.
25. 25. Kotera, J., Fujishige, K., Imai, Y., Kawai, E., Michibata, H., Akatsuka, H., Yanaka, N. & Omori, K. (1999) Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiesterases. Eur. J. Biochem. 262, 866-872.
26. 26. Kotera, J., Fujishige, K., Yuasa, K. & Omori, K. (1999) Characterization and phosphorylation of PDE10A2, a novel alternative splice variant of human phosphodiesterase that hydrolyzes cAMP and cGMP. Biochem. Biophys. Res. Commun. 261, 551-557.
27. 27. Altschul, S.F., Gish, W., Miller, W., Myers, E.W. & Lipman, D.J. (1990) Basic local alignment search tool. J. Mol. Biol. 215, 403-410.
28. 28. Kotera, J., Yanaka, N., Fujishige, K., Imai, Y., Akatsuka, H., Ishizuka, T., Kawashima, K. & Omori, K. (1997) Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal development. Eur. J. Biochem. 249, 434-442.
29. 28a. Harlow, E. & Lane, D. (I988) Antibodies: a Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
30. 29. Proudfoot, N.J. & Brownlee, G.G. (1976). 3′ Non-coding region sequences in eukaryotic messenger RNA. Nature 263, 211-214.
31. 30. Beavo, J.A., Conti, M. & Heaslip, R.J. (1994) Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol. 46, 399-405.
32. 31. Saeki, T., Adachi, H., Takase, Y., Yoshitake, S., Souda, S. & Saito, I. (1995) A selective type V phosphodiesterase inhibitor, E4021, dilates porcine large coronary artery. J. Pharmacol. Exp. Ther. 272, 825-831.
33. 32. Lineweaver, H. & Burk, D. (1934) The determination of enzyme dissociation constants. J. Am. Chem. Soc. 56, 658-666.
34. 33. Harrison, M.B., Wiley, R.G. & Wooten, G.F. (1992) Changes in D2 but not D1 receptor binding in the striatum following a selective lesion of striatopallidal neurons. Brain Res. 590, 305-310,
35. 34. Moine, C.L. & Bloch, B. (1995) D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neural. 355, 418-426.
36. 35. Sanborn, B.M., Heindel, J.J. & Robinson, G.A. (1980) The role of cyclic nucleotides in reproductive processes. Annu. Rev. Physiol. 42, 37-57.
37. 36. Morena, A.R., Boitani, C., Grossi, S.D., Stefanini, M. & Conti, M. (1995) Stage and cell-specific expression of the adenosine 3′,5′ monophosphate-phosphodiesterase genes in the rat seminiferous epithelium. Endocrinology 136, 687-695.
38. 37. Naro, F., Zhang, R. & Conti, M. (1996) Developmental regulation of unique adenosine 3′,5′-monophosphate-specific phosphodiesterase variants during rat spermatogenesis. Endocrinology 137, 2464-2472.